Literature DB >> 16622230

Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response.

R Phillips1, C Horsfield, J Mangan, K Laing, S Etuaful, P Awuah, K Nyarko, F Osei-Sarpong, P Butcher, S Lucas, M Wansbrough-Jones.   

Abstract

Cytokine mRNA expression in biopsies of Mycobacterium ulcerans-infected human tissue was investigated using real-time PCR, and the findings were correlated with the clinical stages of disease and histopathologies. A broad range of cytokine mRNAs were detected in 16 early nodules and 28 late-stage ulcers, including those for the Th1 cytokines tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma) and the Th2 cytokine interleukin 10 (IL-10). IFN-gamma was strongly expressed in both nodules and ulcers, suggesting that a Th1 response begins early in the disease. There was a significantly higher expression of IL-8 and other proinflammatory cytokines in results from 32 biopsies with neutrophilia than in those from 12 biopsies without acute inflammation. Ten tissue samples containing granulomas showed high mRNA expression for IFN-gamma, IL-1beta, IL-12p35, IL-12p40, IL-15, and TNF-alpha relative to 34 tissue samples without granulomas. These results suggest that the human immune response to M. ulcerans is similar to that seen with some other mycobacteria despite the presence of the toxin mycolactone in the tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622230      PMCID: PMC1459747          DOI: 10.1128/IAI.74.5.2917-2924.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer.

Authors:  R Phillips; C Horsfield; S Kuijper; A Lartey; I Tetteh; S Etuaful; B Nyamekye; P Awuah; K M Nyarko; F Osei-Sarpong; S Lucas; A H J Kolk; M Wansbrough-Jones
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.

Authors:  Emmanuelle Coutanceau; Laurent Marsollier; Roland Brosch; Emmanuelle Perret; Pierre Goossens; Myriam Tanguy; Stewart T Cole; Pamela L C Small; Caroline Demangel
Journal:  Cell Microbiol       Date:  2005-08       Impact factor: 3.715

Review 4.  Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors.

Authors:  Y Stienstra; W T van der Graaf; G J te Meerman; T H The; L F de Leij; T S van der Werf
Journal:  Trop Med Int Health       Date:  2001-07       Impact factor: 2.622

5.  The pathology of Mycobacterium ulcerans infection.

Authors:  J Hayman; A McQueen
Journal:  Pathology       Date:  1985-10       Impact factor: 5.306

Review 6.  Protection against tuberculosis: cytokines, T cells, and macrophages.

Authors:  S H E Kaufmann
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

7.  Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

Authors:  K M George; L P Barker; D M Welty; P L Small
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis.

Authors:  H Aung; Z Toossi; S M McKenna; P Gogate; J Sierra; E Sada; E A Rich
Journal:  Tuber Lung Dis       Date:  2000

9.  Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.

Authors:  K M Dobos; E A Spotts; B J Marston; C R Horsburgh; C H King
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

10.  The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection.

Authors:  J L Stanford; W D Revill; W J Gunthorpe; J M Grange
Journal:  J Hyg (Lond)       Date:  1975-02
View more
  10 in total

1.  Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Authors:  Brendon Y Chua; Timothy P Stinear; Kirstie M Mangas; Andrew H Buultjens; Jessica L Porter; Sarah L Baines; Estelle Marion; Laurent Marsollier; Nicholas J Tobias; Sacha J Pidot; Kylie M Quinn; David J Price; Katherine Kedzierska; Weiguang Zeng; David C Jackson
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 2.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

3.  Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.

Authors:  Egídio Torrado; Sarojini Adusumilli; Alexandra G Fraga; Pamela L C Small; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

4.  Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.

Authors:  H S Schipper; B Rutgers; M G Huitema; S N Etuaful; B D Westenbrink; P C Limburg; W Timens; T S van der Werf
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

Review 5.  Buruli ulcer disease: prospects for a vaccine.

Authors:  Kris Huygen; Ohene Adjei; Dissou Affolabi; Gisela Bretzel; Caroline Demangel; Bernhard Fleischer; Roch Christian Johnson; Jorge Pedrosa; Delphin M Phanzu; Richard O Phillips; Gerd Pluschke; Vera Siegmund; Mahavir Singh; Tjip S van der Werf; Mark Wansbrough-Jones; Françoise Portaels
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

6.  Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.

Authors:  Raphael Bieri; Miriam Bolz; Marie-Thérèse Ruf; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2016-02-10

7.  Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.

Authors:  Norman Nausch; Daniel Antwi-Berko; Yusif Mubarik; Kabiru Mohammed Abass; Wellington Owusu; Ellis Owusu-Dabo; Linda Batsa Debrah; Alexander Yaw Debrah; Marc Jacobsen; Richard O Phillips
Journal:  PLoS Negl Trop Dis       Date:  2017-02-27

8.  In Silico Prediction of Epitopes in Virulence Proteins of Mycobacterium ulcerans for Vaccine Designing.

Authors:  Taruna Mohinani; Aditya Saxena; Shoor Vir Singh
Journal:  Curr Genomics       Date:  2021-12-31       Impact factor: 2.689

9.  Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.

Authors:  Audrey Tanghe; Jean-Pierre Dangy; Gerd Pluschke; Kris Huygen
Journal:  PLoS Negl Trop Dis       Date:  2008-03-19

10.  Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone.

Authors:  Emmanuelle Coutanceau; Jeremie Decalf; Angelo Martino; Aurélie Babon; Nathalie Winter; Stewart T Cole; Matthew L Albert; Caroline Demangel
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.